Keywords: distraction distraction osteogenesis distractor intramedullary ISKD kinetic lengthening skeletal a b s t r a c t Background: The intramedullary skeletal kinetic distractor (ISKD) is one of the relatively recent methods developed to overcome the complications of conventional bone lengthening methods, such as external fixators. These complications include pain, muscle transfixation, pin-tract infection, reduced joint motion, and prolonged fixation time. However, ISKD-specific complications such as uncontrollable lengthening and hardware failure make the outcomes of ISKD lengthening questionable. In this article, we review published literature on the efficacy and complications of the ISKD device. Methods: A database search was conducted in PubMed, Ovid Medline, Ovid Full Text, Springer link, EBSCO Medline, Science Direct, ISI Web of Knowledge, and Google Scholar. We included English articles with extractable data about the study population and outcomes, reporting ISKD implantation in the femur or tibia of skeletally mature patients. The included studies were too heterogeneous for a metaanalysis to be performed. Results: Fifteen of 89 potentially relevant citations were found to match the inclusion criteria. The most common causes of limb-length discrepancy indicating an ISKD implantation were traumatic and congenital. The average lengthening achieved, average patient discharge period, mean follow-up time, average consolidation time and index, average distraction time and index, and number of patients requiring additional operations as well as other outcome measures are discussed in this article. The most common complications were runaway nail, difficulty in achieving lengthening, and poor bone regenerate formation. Conclusion: Even though the classic complications of external lengthening are virtually diminished, alterations to the current design of the ISKD are needed to avoid the distraction-related complications. Risk of unplanned surgery could be minimized through proper patient selection and proper surgical techniques. 中 文 摘 要 背景：髓內骨骼延長釘(ISKD)是為了克服常規骨骼延長的方法，如外固定支架，的併發症而新近發展的技 術。常規骨骼延長方法的併發症包括疼痛，肌肉釘住，針道感染，減少關節運動和長期的固定時間。然而， ISKD 特有的併發症，如無法控制的延長和硬件故障都令人懷疑ISKD的療效。在本文中，我們將回顧已發表 關於ISKD療效和併發症的文獻。 Journal of Orthopaedics, Trauma and Rehabilitation J o u r n a l h o m e p a g e s : w w w . e -j o t r . c o m & w w w . e j o t r . o rg http://dx.
Introduction
Distraction osteogenesis is the traditional gold standard method for correction of limb-length discrepancy. Circular external fixators (e.g., Ilizarov fixator or Taylor spatial frame) or monolateral fixators (e.g., Orthofix, Orthofix Inc., McKinney, TX, USA or EBI, Dynafix, Parsippany, NJ, USA) provide the traditional means for inducing and utilizing distraction osteogenesis. The most frequently experienced complication is pin-site infection. Minor pin-tract infection rates range from 2% to 80%, and major pin-tract infection rates that reach 23% have been reported. 1, 2 Soft-tissue transfixation by wires and pins also can cause muscle contractures, joint stiffness, and pain. 3e5 However, pain is the most common patient complaint during limb lengthening, and may be intense during the 1 st postoperative days. Contraction of any muscle transfixed by a pin or wire is particularly painful and often requires medication with narcotics. Night pain and pain during therapy caused by stretching of the muscles and nerves is common and can lead to loss of appetite and even depression. 5, 6 The continued presence of an awkward and painful external fixation device, combined with the mental stress and unknown outcome, can lead to variable psychological behaviours. Neurovascular structures are also vulnerable both at the time of screw or wire insertion as well as during distraction. 7, 8 Hip and knee complications, including dislocation and subluxation, are often reported during and after limb lengthening. Also, joint stiffness may occur because of long-standing contractures and increased pressure on the joint surface during lengthening. 4 Pain often diminishes and may inhibit functional loading and movement of the joints during the lengthening process, so loss of range of motion is also common. Lengthening with external fixators can induce secondary axial deformity during or after the lengthening process. After fixator removal, refractures of the regenerated bone can occur. The long period of external fixation delays the patient's return to normal daily activities. Clearly, it is desirable to use some type of implantable device in limb lengthening to eliminate these complications.
Bost and Larsen 9 reported lengthening of the femur using both an external device and an unlocked, first-generation intramedullary nail to eliminate the difficulty of controlling the alignment and avoid the relatively high risk of the incidence of axial deformity that occurs with fixators alone. Paley et al 10 described the technique of lengthening over a locked intra-medullary nail, which allows early removal of the external device after distraction. The locked intramedullary nail provides stability during the consolidation process, which reduces pain, lessens further pin-site problems, and increases patient acceptance of the procedure. Nevertheless, deep osteomyelitis can occur if pin-tract infections spread to the tissue surrounding the intramedullary nail. 11, 12 Another method for safer bone lengthening is lengthening followed by nailing, which minimizes the period of external fixator usage. It uses the application of an Ilizarov external fixator with the principle of distraction osteogenesis to achieve the desired length, and then in another surgery, the external fixator is removed and an interlocking nail is inserted. This allows the patient's bone to consolidate within the interlocking nail alone. This method provides easier and earlier patient rehabilitation because the time of external fixator use is shortened. Nevertheless, complications such as pin-tract infection, muscle and nerve irritation, and joint stiffness are still present at the time of fixator removal. Moreover, if a concurrent infection extends in the presence of the interlocking nail, it often leads to catastrophic deep infection. 13 The goal of recent advances in the field of limb lengthening is to increase patient acceptance and comfort by avoiding the common complications of the classic external fixators. 14 One important achievement is the use of totally implantable intramedullary, selfdistracting lengthening nails. 15e18 The Albizzia nail (DePuy, Villeurbanne, France) is a mechanically driven device developed in the 1990s. Its lengthening mechanism is activated by rotations of 20 around the horizontal axis. One significant drawback is severe pain that is sometimes associated with the large magnitude of torsion required for lengthening. This resulted in a high incidence of either failed lengthening or the need to return to the operating theatre and closed manipulation of the limb under anaesthesia until distraction could recommence.
The Fitbone (Wittenstein, Igersheim, Germany) is another fully implantable lengthening nail. Its lengthening mechanisms are driven by an internal motor activated by an external transmitter. 12 There have been promising results in the literature, with good return to function and ease of use. However, a significant rate of device failure has been reported, with up to 25% of patients never achieving the desired distraction length. 23 The intramedullary skeletal kinetic distractor (ISKD, Orthofix Inc., McKinney, TX, USA) is another one of those devices. It is designed to lengthen the bone gradually as a result of small, deliberate rotatory movements between 3 and 9 at the osteotomy site around the longitudinal axis of the nail. Such rotatory movements can be done during normal daily activities such as walking, 19 as has been originally described by Cole et al, 15 and the ISKD is the only intramedullary lengthening device approved by the Food and Drug Administration (FDA).
Although intramedullary lengthening was introduced primarily so that the problems of external fixators can be avoided, significant complications have been reported with this procedure, of which uncontrolled lengthening and nondistractible nail are the most important. 19e21 Reports of nondistracting or runaway ISKD nails are now present, with an incidence of up to 45%.
In this systematic review, our goal is to review and discuss the published literature that describes and criticizes the ISKD as a method for bone lengthening in different groups of patients, to reach a conclusion about the efficacy of ISKD, help surgeons to carefully select the appropriate indicated patients for that procedure, and reduce the risk of unplanned surgery by avoiding the most common surgical pitfalls that reportedly cause complications.
Methods
We carried out a systematic review of published studies reporting the use of ISKD in limb lengthening. We searched eight databases (Pub Med, Springer, EBSCO Medline, Journal Ovid Full Text, OVID Medline Search, Science Direct, ISI Web of Knowledge, and Google Scholar) for relevant publications. We also searched the bibliographies of included articles to identify additional relevant articles. References of included articles and previous reviews and meta-analyses were reviewed to identify additional relevant articles. Between August 2012 and November 2012, routine searches were performed with the following keywords in various combinations: ISKD; intramedullary; skeletal; kinetic; distractor; distraction; lengthening. Two reviewers (M. Abdelmohsen and M. Amgad) independently reviewed the title and abstracts to identify potentially relevant studies for full-text assessment. Any disagreements on which studies to include were resolved by consensus.
Inclusion criteria
We included original peer-reviewed research articles regardless of the study design (prospective, retrospective, cross-sectional, or interventional). Our search was limited to studies published in the English language in a human, skeletally mature patient population.
Exclusion criteria
Exclusion criteria included studies in languages other than English; studies performed on animals; studies describing lengthening techniques using devices other than ISKDs; and unpublished data and abstracts for which full reports were not available.
The following data were extracted from each of the included studies: demographic characteristics of the study population, various prognostic parameters, and complications resulting from the procedure. The included studies were also judged with a checklist of potential sources of bias, as can be seen in Table 1 . 15,17,18,20e30 Results Studies that met the inclusion criteria were compiled, read, and tabulated. Two studies by Hankemeier et al 14, 17 referred to the same patient cohorts, so only one of them was included in the results tables. Table 1 outlines the quality assessment of the included studies in our systematic review. Table 2 lists the demographic parameters of the patients included in each study. Many of the studies we found reported the results of ISKD lengthening in femora only, although the studies by Cole et al, 15 Hankemeier et al, 14, 17 Wang and Edwards, 23 Schiedel et al, 27 and Kenawey et al 29 reported tibial lengthening as well regardless of the complications. The most common causes of limb-length discrepancy necessitating ISKD implantation were trauma, congenital causes, and cosmetic surgical procedures. All of the patients in the included studies were adults, with a mean age ranging from 24 years to 40 years. Table 3 compared the different complications encountered in femoral and tibial ISKDs, wherever mentioned. Although five studies mentioned the use of ISKD in the tibia and femora, yet only three of them mentioned the rate of complications encountered specifically for each. 23, 27, 29 Table 4 summarizes the prognostic parameters of each of the studies, where mentioned. The parameters include the mean time to full weight bearing, mean lengthening achieved, mean lengthening rate, mean time to patient discharge, mean follow-up time, number and percentage of limbs in which satisfactory lengthening was achieved, mean consolidation time and index, mean distraction index, mean intraoperative blood loss, and the number and percentage of patients in whom additional surgical procedures were performed.
Regarding complications, two studies reported no complications in any of the cases treated with ISKD. 17, 30 Of the studies that did mention complications, runaway nails and nondistracting nails were most commonly reported. A study by Burghardt et al 28 also found a rather large number of cases that had hardware malfunction. Other reported complications include infection (superficial and deep), insufficient bone regenerate (IBR; causing nonunion), compartment syndrome, premature consolidation, angular deformity, and joint contracture. Detailed numbers of the mentioned ISKD complications and reported complications are summarized in Table 5 .
Discussion
Six of the 14 included studies explicitly stated their inclusion and exclusion criteria of the study population and only eight reported the consolidation and distraction indices of included cases. Thus, in about half of the articles that met the inclusion criteria, it was not possible for us to discern whether any cases were excluded based on the outcomes or whether unfavourable outcomes were underreported. As with most research on surgical procedures, it was not possible to blind participants and personnel to the intervention, nor was there any allocation concealment in any of the studies. These factors, among others, present potential sources of bias that need to be taken into consideration when evaluating the evidence presented in this review.
There are many reported advantages of using the ISKD over conventional methods for bone lengthening. There is increased patient comfort and an improved satisfaction with the higher mobility that the ISKD grants. Moreover, the fact that the ISKD is completely intramedullary means that there is virtually no risk of pin-track infections (which may reach up to 80%), as is the case with the Ilizarov frame. Of course, this comes with its own price, as the intramedullary nature of the device makes it impossible to modify or "reset" throughout the lengthening procedure. It should not be surprising that the ability to control lengthening is compromised in a mechanical patient-centred lengthening model. The patient's level of activity and compliance may not be homogenous, and may be responsible for the variability in daily lengthening. To account for this problem, the ISKD implant is coupled with an external sensor that makes the patient aware of daily changes in the nail's length.
Despite this, uncontrolled rapid lengthening of > 1.5 mm per day (or runaway nail as it came to be known) has been repeatedly reported in the literature as an ISKD-specific complication. 20e29 This runaway nail complication was reported by most of the included studies that did mention complications.
One possible explanation is that the patients were not acquainted with the sensor or the device. Also, the patient's level of activity may not be homogeneous, and may be responsible for the variability in daily lengthening. That is why it has been argued by Thonse et al 31 that incompetent patients and patients who are not fully capable of grasping the mechanical lengthening mechanism should be excluded from ISKD procedures and scheduled for one of the more conventional methods such as the Ilizarov frame. Another possibility is that the problem is in the device itself, in which case the design would need to be revised, as has been argued by Kenawey et al 29 and Papanna et al. 22 This finding was supported by Reynders, 24 who claimed that the cause may be because a (too sensitive) distal clutch can be activated by muscle contractions. Indeed, Simpson et al 11 found that the external ISKD sensor starts to lose sensitivity when thigh circumference exceeds 20 cm in the 23 showed that when the length of the outer nail portion in the distal fragment is < 100 mm, runaway nail is more likely to occur. This is consistent with the findings by Simpson et al, 18 who had seven runaway nails in 33 femoral lengthening procedures using an ISKD nail (21%), and stated that a length of < 80 mm was associated with runaway nail complication. Although Kenawey et al 29 had nine runaway nails in 45 femoral lengthening cases (20%) and none in the patients in the tibial lengthening group, they could not support this relation. Simpson et al 18 mentioned that previous intramedullary nailing was also found to predispose to uncontrolled lengthening. Difficult-to-distract nails is another common complication of ISKD. Nondistracting nails were defined as nails that fail to distract in situ despite increasing the activity level and manually rotating the lower extremities by the patients themselves or with assistance from family members. Kubiak et al 21 first addressed why some nails had difficulty distracting. After having three nondistracting nails in 11 femoral lengthening procedures, they explained that the use of a straight nail such as the ISKD in a curved femur predisposes to binding of the anterior cortices at the osteotomy site and failure to lengthen. Simpson et al 18 reported eight non-distracting nails in their 33 femoral ISKD lengthening procedures, and subsequently developed the previous argument by suggesting that the ease of nail advancement is related to the length of the outer portion of the nail situated in the distal bone fragment. The likelihood of nondistracting nail is increased when there is a longer segment of bone in contact with the thick segment of the nail. They found that a length of > 125 mm is associated with difficult-to-distract nails and < 80 mm is associated with runaway nails, respectively. As mentioned, Wang et al 23 in their study demonstrated that patients with runaway nails had a significantly shorter segment of the thick portion of the nail in the distal fragment than normally distracting or difficult-to-distract nails. However, perhaps because of smaller numbers (difficult-to distract nails ¼ 3), they were unable to confirm that having a longer length of the thick portion of the nail in the distal fragment is associated with difficult-to-distract nails. Difficult-to-distract nails also might be related to the design of the ISKD. 23 However, Schiedel et al 27 argued, rather convincingly, that this may not necessarily be true, given the fact that the manufacturer prohibits full weight bearing until there is radiological evidence of consolidation. It may be true that the compressive forces related to premature weight bearing opposed full distraction of the ISKD nails. In order to avoid the aforementioned complications, Wang et al 23 recommended an osteotomy location between 100 mm and 120 mm from the distal end of the thick segment of the nail. Further, Kubiac et al 21 recommended removal of a wedge of bone and ensuring no cortical contact at the osteotomy site to avoid this complication. Also, they recommended prophylactic release of the iliotibial tract in cases in which the distraction is planned for > 4 cm, to avoid the possible effect of the soft-tissue tension on the nail lengthening mechanism. Simpson et al 18 supposed that a tight medullary canal interferes with nail distraction; that is why they advised overreaming by 2.5e3.0 mm to facilitate nail distraction, unless an intramedullary nail had been used previously in the femur, in which case the overreaming should be less: perhaps 2e2.5 mm. Another common complication with ISKD is IBR. Patients with IBR are those who require additional surgeries to achieve union. Regenerate failure was classified as partial failure of regenerate formation causing partial bony defect (type I) or complete failure of regenerate formation causing complete segmental bony defect (type II), which is subdivided according to the length, < 3 cm (type IIa) or > 3 cm (type IIb). 29 Of 57 lengthening procedures, Kenawey et al 29 reported 12 cases (21%) of IBR formation resulting in nonunion (11 femoral and 1 tibial), and Wang and Edwards 23 reported six cases of delayed union (37.5%). In another study by Kenawey et al, 29 they reported eight cases of 37 cases (21%). 20 Simpson et al 18 also reported three patients of 33 femoral lengthening procedures with IBR.
IBR formation depends on many factors; the most critical of them being distraction rate and rhythm. Kenawey et al 20 stated that age > 30 years, smoking, length gain > 4 cm, osteotomy at the same site of previous trauma or surgery, and acute correction of associated deformities are other important risk factors for IBR. 20 The distraction rate predisposing to insufficient regenerate formation has been reported to be 1.5 mm/day by Kenawey et al 20, 29 and Wang et al, 23 whereas Kubiac et al 21 reported it to be 3 mm/ day. When Kenawey et al 29 compared the femoral and tibial lengthening groups to factors that may affect formation and healing of bone regenerate, they found the rate of poor bony regenerate to be less with tibial lengthening cases compared to femoral cases. Their explanation was attributed to the fact that the femoral group had significantly higher distraction rates than the tibial group. Six of nine patients with runaway nails had IBR in their study. No statistically significant differences were found between both groups regarding age, percentages of smokers, number of concomitant corrections of associated deformities, performing osteotomies at the same level of a previous trauma or surgery, or the magnitude of length gain. Furthermore, no significant difference could be attributed to the etiology of shortening.
Wang and Edwards 23 found no statistically significant difference between femoral and tibial lengthening in terms of length gained, proportion of runaway nails, and proportion of difficult-to-distract nails. Nevertheless, they found a greater proportion of poor regenerate formation in the tibiae in comparison with the femora. They claimed that the number of previous surgical procedures on the lengthened bone was significantly associated with an increased likelihood of poor bone regenerate formation. This, they proposed, may be caused by poor bone quality and blood supply to the surrounding tissues, in addition to extensive scarring. That is why Wang and Edwards 23 advocate the use of traditional lengthening with Ilizarov fixation when dealing with patients who have had multiple prior open procedures.
The designer of the ISKD nail, Cole et al, 15 included in their article a description of 14 cases of tibial distraction using the device.
However, consolidation index, rates of poor regeneration, and other complications were not mentioned.
Regarding frank device failure, which is defined as breakage of the nail or absolute failure of the mechanism to lengthen despite a complete osteotomy, it can result from either a manufacturing defect of the nail or a biologically related situation. A study by Burghardt et al 28 specifically studied the hardware failure complication in a large number of surgically treated limbs (210 limbs, 242 ISKDs) and found a rather large number of cases that had hardware malfunction. They reported 15 cases of hardware malfunction in 12 of 180 patients representing an overall failure rate of 6.2%, with fracture of the device occurring in 10 of the 15 failures; subsequent nonunion developed in three of these 10 nails, which presumably caused an overloading of the nail and resulted in breakage. A total of 14 lengthening procedures were performed in the femur (8 of which received femoral nails and 6 received tibial nails) and one was performed in the tibia. Details of the 15 reported failures were as follows: in four cases, a disengaged key ring was noted upon device removal; in four cases lengthening failed because of an error in the manufacturer's assembly; in two cases there were mirrorimage nail fractures of the female component resulting in torsion overload; in two cases the key ring and female part broke after nonunion; in two cases there was nonunion caused by torsion overload; in one nail, the lengthening mechanism jammed as a result of being forcefully implanted when it deviated from the prereamed canal into an unreamed portion of the distal metaphysis. This was recognized during the surgical procedure, and the ISKD was immediately exchanged for another nail that functioned correctly. This damage demonstrates that a mechanically complex nail requires more delicate handling than a standard intramedullary nail.
When breakage occurred before the bone was fully consolidated, it is possible that the nail was damaged through an overload during the vulnerable period of the lengthening process. If this is the case, it may be prudent to extend the period before allowing full weight bearing. Additionally, patients should be advised to restrict weight bearing to < 50 lb (22.7 kg) until sufficient consolidation has taken place. To avoid these complications, patients with delayed consolidation need special attention. Burghardt et al 28 believe full weight bearing should be avoided until solid radiological healing has been achieved. In the event of nonunion, consideration should be given to bone grafting and nail exchange earlier than in those with normal trauma.
Because most failures in this study were recognized radiologically at follow-up visits or during removal of the nail, special attention should be paid to the early recognition of implant fractures on radiography. Retrieved nails should undergo a careful inspection by the surgeon for visible defects and to ensure that no broken pieces remain in the limb after surgery.
Despite these failures, Burghardt et al 28 stated that the ISKD is well constructed and is acceptably reliable. Although 15 failures were observed, only three patients required an additional surgical procedure to gain the desired length. Furthermore, none of the failures resulted in catastrophic complications or led to loss of length.
It is worth mentioning that despite the large number of patients included in the study of Burghardt et al, 28 the study discusses only the hardware malfunction complication in 15 patients. No other complications regarding distraction or union were mentioned. That is why the interpretation of the study by Burghardt et al 28 in our review tables was confined only to specific few parts in our tables.
Among the important publications we found was a study by Thonse et al, 31 reporting their experience with 116 ISKD implant cases that were treated over the course of 4 years. An early review of follow-up of the first 41 patients showed that 70% of these patients experienced distraction that progressed normally. Twenty percent (8 of 41 patients) had a difficult time inducing distraction, and 10% (4 of 41 patients) experienced distraction that progressed too rapidly. Even though they did not report demographic characteristics or prognostic parameters of their patient cohort, they reported a valuable set of general inclusion and exclusion criteria of patients regarding ISKD lengthening. Important classic exclusion criteria include skeletal immaturity, limb-length discrepancy < 20 mm or > 80 mm, active infection, unstable hip/knee joints, metabolic diseases, systemic disease, and smoking. Furthermore, it has to ascertained that bones are of adequate length and that the medullary canals have the appropriate diameter needed to accommodate the ISKD implant. With the femur, the nail is 255 mm long and has a diameter of 12.5 mm (reamed to 14.5 mm). With the tibia, the nail is 215 mm long and has a diameter of 10.8 mm (reamed to 12.5 mm).
Although the ISKD has been approved by the FDA, the UK National Institute for Health and Clinical Excellence (NICE) did not recommend the use of intramedullary lengthening devices after examining the published literature. 32 Schiedel et al 27 concluded, in contrast to the NICE recommendations, that the overall reliability of the ISKD in the femur was good, with 52 of 58 lengthening procedures (98%) being successful. They stated that ISKD can be recommended with good patient selection and in pure lengthening up to 5 cm without associated correction of axial deformity. In the tibia, although the implant functioned in nine of 11 cases, successful treatment was obtained in only five. The tibia results detracted from the overall success of this implant, with 57 of 69 patients (83%) reaching their goal, but it is still comparable with other experiences with this implant.
We agree with the NICE recommendations for the current ISKD design, but we believe that proper patient selection, surgical technique, strict follow-up, and patient compliance along with some technical modification of the current design will help to easily overcome the aforementioned complications.
For tibial ISKD, patients who underwent multiple surgical intervention and patients with unfavorable soft tissue conditions and extensive scarring in whom the healing power and local blood supply are questionable should be excluded from the procedure. For femoral ISKD, patients with excessively curved femora should be excluded from the procedure and shifted to one of the conventional methods.
Regarding the technical modifications related to the implant itself, revisions of the current ISKD design are recommended so that the risk of unplanned surgery could be minimized. These revisions may include slight curvature of the femoral ISKD components to withstand the femoral bowing without intervening with the lengthening mechanism. Also, as previously mentioned that the risk of runaway nail is directly proportionate to the length of the outer portion of the nail inside the distal fragment, the outer portion of the nail could be lengthened more, providing a wide longitudinal opening on both sides to accommodate the two distal screws of the inner portion freely and allow its distraction and the 3e9 of rotation without or with minimal impingement. Also, revision of manufacturing of the sensor should be done to overcome the loss of sensor sensitivity in patients with thigh circumference < 20 cm. Another possible modification is the revision of the distal clutcherod relationship, so that the too-sensitive distal clutch could be sensitive only to the physiologic movements rather than any muscle contractions. In addition, revision of assembly of the junction between the nail telescopic mechanisms, which is the weakest portion of the nail where most cases of nail fracture occur, should be considered. After reviewing the literature we believe that these modifications, in addition to patient selection and follow-up, will solve most of the ISKD related complications.
Conclusion
The ISKD offers the advantages of early rehabilitation, early full weight bearing, and excellent functional results. It also provides stable intramedullary fixation and avoids the inevitable disadvantages of external fixators, such as pin-track infection, painful scars, and discomfort caused by long-term use of the device.
Disadvantages of the ISKD include difficulties in controlling the distraction, especially during femoral lengthening. Distraction rates > 1.5 mm/day are a risk factor for runaway nail and IBR formation with subsequent delayed union. In addition, difficult-to-distract nails and poor bone regenerate formation are other complications that occur with inappropriate patient selection and poor surgical technique. That is why, after analysing the previous studies, surgical technique, patient education, and strict follow-up along with some technical modifications of the current design of ISKD will help to avoid the related complications, and subsequently provide the surgeon another reliable option for bone lengthening with good efficacy and improved patient comfort.
